33 related articles for article (PubMed ID: 1332625)
1. Phase II study of carboplatin in non-small cell lung cancer.
Tamura T; Shinkai T; Eguchi K; Sasaki Y; Fujiwara Y; Fukuda M; Ohe Y; Nakagawa K; Minato K; Saijo N
Jpn J Clin Oncol; 1989 Mar; 19(1):51-5. PubMed ID: 2537907
[TBL] [Abstract][Full Text] [Related]
2. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer].
Furuse K; Fukuoka M; Kurita Y; Ariyoshi Y; Niitani H; Yoneda S; Fujii M; Hasegawa K; Nishiwaki Y; Tamura M
Gan To Kagaku Ryoho; 1992 Jun; 19(6):879-84. PubMed ID: 1318698
[TBL] [Abstract][Full Text] [Related]
3. [Preclinical and clinical evaluation of toxicity and antitumor activity of cisplatin analogues].
Ariyoshi Y; Ota K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1379-85. PubMed ID: 2658826
[TBL] [Abstract][Full Text] [Related]
4. [A phase I study of carboplatin].
Ogawa M; Imajo K; Horikoshi N; Inoue K; Mukaiyama T; Yamazaki H; Ueno K; Nakamura T; Aiba K; Kuraishi Y
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1292-6. PubMed ID: 3034170
[TBL] [Abstract][Full Text] [Related]
5. [A phase II study of carboplatin in lung cancer. The Carboplatin Cooperative Study Group].
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2781-5. PubMed ID: 2843133
[TBL] [Abstract][Full Text] [Related]
6. [Development of platinum analogues for the treatment of lung cancer].
Nakai Y
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2157-62. PubMed ID: 1332625
[TBL] [Abstract][Full Text] [Related]
7. [Nedaplatin].
Ota K
Gan To Kagaku Ryoho; 1996 Feb; 23(3):379-87. PubMed ID: 8712835
[TBL] [Abstract][Full Text] [Related]
8. [Cisplatinum compounds].
Ota K
Gan To Kagaku Ryoho; 1993 Jan; 20(1):50-8. PubMed ID: 8380687
[TBL] [Abstract][Full Text] [Related]
9. Challenges in advanced NSCLC: optimizing platinum-based chemotherapy and treating special populations.
Belani CP
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S10-22. PubMed ID: 19780242
[TBL] [Abstract][Full Text] [Related]
10. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.
Vilmar A; Sørensen JB
Lung Cancer; 2009 May; 64(2):131-9. PubMed ID: 18804893
[TBL] [Abstract][Full Text] [Related]
11. Current status and future prospects for satraplatin, an oral platinum analogue.
Choy H; Park C; Yao M
Clin Cancer Res; 2008 Mar; 14(6):1633-8. PubMed ID: 18347164
[TBL] [Abstract][Full Text] [Related]
12. [New anthracycline analogues in the treatment of lung cancer].
Ueoka H; Ohnoshi T; Kimura I
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2146-9. PubMed ID: 1332624
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
